Prevalence of sickle cell disease and sickle cell trait among children below 17 years of age attending Entebbe regional referral hospital in Wakiso district. A cross-sectional study.
DOI:
https://doi.org/10.51168/sjhrafrica.v7i3.2407Keywords:
Sickle cell disease, sickle cell screening, sickle cell trait, children below 17 years, Entebbe Regional HospitalAbstract
Background:
Sickle cell disease (SCD) is a genetic disorder that affects the shape of hemoglobin in the red blood cell, leading to the formation of a sickle shape. This study aims to determine the Prevalence of sickle cell disease and sickle cell trait among children below 17 years of age attending Entebbe Regional Hospital, Wakiso district, Uganda.
Methods:
This was a prospective cross-sectional study conducted at Entebbe regional referral hospital, which included 100 respondents who were selected using a purposive and convenience sampling technique, and data were collected prospectively by administering researcher-guided questionnaires.
Results:
The study participants, 55% (55/100), were female, and the age range of respondents was 0– 17 years, 45.0% (45/100) were aged 6-11 years. The Prevalence of sickle cell disease and sickle cell trait among respondents was 19.0% (19/100), with 6% (6/100) respondents found having the homozygous form, HbSS, and 13% (13/100) found having the heterozygous form, HbAS. 86% (86/100) of the respondents had heard about sickle cell, and the majority, 92% (92/100) of the parents had children that had never been screened for sickle cell, with only 8% (8/100) of the children ever screened. 39% (39/100) of the parents reported knowing the cause of sickle cell disease, with the majority, 61% (61/100), not knowing how SCD is caused. 65% (65/100) of the parents of respondents reported that sickle cell is transmitted from parent to child, 17% (17/100) did not know how SCD is transmitted.
Conclusions:
The prevalence of sickle cell disease and sickle cell trait was high, while the majority of the participants lacked knowledge about sickle cell screening.
Recommendations:
There is a need for health facilities to scale up screening services for sickle cell disease in the community so as to enable early diagnosis and treatment of the disease and reduce morbidity and mortality.
References
Adewoyin, A. S., Alagbe, A. E., Adedokun, B. O., & Idubor, N. T. (2015). Knowledge, attitude, and control practices of sickle cell disease among youth corps members in Benin City, Nigeria. Annals of Ibadan Postgraduate Medicine, 13(2), 100–107.
Al-Azri, M., Al-Hashmi, S., Al-Shamsi, M., & Al-Kindi, M. (2016). Knowledge and attitudes toward genetic screening for sickle cell disease among adults in Muscat, Oman. Oman Medical Journal, 31(5), 378–384. https://doi.org/10.5001/omj.2016.75
Ameade, E. P. K., Mohammed, B. S., Helegbe, G. K., & Yakubu, A. (2015). Sickle cell gene transmission: Do public servants in Tamale, Ghana, have adequate knowledge? BMC Research Notes, 8, 299. https://doi.org/10.1186/s13104-015-1243-6
Harrison, S. E., et al. (2017). Disclosure of sickle cell carrier status and associated factors among Ugandan populations. BMC Public Health, 17, 248. https://doi.org/10.1186/s12889-017-4162-9
Matovu, J. (2022). Prevalence of sickle cell disease among children aged 1–15 years attending Luwero Hospital, Luwero District, Uganda. Unpublished undergraduate dissertation.
Namukasa, C., et al. (2024). Burden of sickle cell trait and factors influencing uptake of screening services among secondary school students in Uganda. African Health Sciences, 24(1), 112–120.
Tusuubira, S. K., Nakayinga, R., Mwambi, B., & Ndeezi, G. (2018). Knowledge, perception, and practices towards sickle cell disease: A community-based study in Uganda. BMC Public Health, 18, 561. https://doi.org/10.1186/s12889-018-5496-4
Watenga, E. K., et al. (2020). Prevalence of sickle cell trait among adolescents in Bungoma County, Kenya. Pan African Medical Journal, 36, 298. https://doi.org/10.11604/pamj.2020.36.298
Asiimwea, C., et al. (2023). Burden of sickle cell disease in sub-Saharan Africa: Current status and future perspectives. African Health Sciences, 23(2), 45–54. https://doi.org/10.xxxx/ahs.v23i2
Centers for Disease Control and Prevention (CDC). (2024). What is sickle cell disease? U.S. Department of Health and Human Services. https://www.cdc.gov/sicklecell
Inusa, B. P. D., Hsu, L. L., Kohli, N., Patel, A., Ominu-Evbota, K., Anie, K. A., & Atoyebi, W. (2019). Sickle cell disease—Genetics, pathophysiology, clinical presentation, and treatment. International Journal of Neonatal Screening, 5(2), 20. https://doi.org/10.3390/ijns5020020
Musyoka, F. M., et al. (2018). Clinical outcomes and associated factors among children with sickle cell disease in Tanzania. BMC Hematology, 18, 25. https://doi.org/10.1186/s12878-018-0118-4
Namazzi, G., et al. (2017). Burden of sickle cell disease in Uganda and associated mortality among children. BMC Public Health, 17, 256. https://doi.org/10.1186/s12889-017-4173-6
Nanbur, S. A., et al. (2018). Prevalence of sickle cell disease among children attending Plateau State Specialist Hospital, Jos, Nigeria. Nigerian Journal of Paediatrics, 45(3), 123–128.
Ndeezi, G., Kiyaga, C., Hernandez, A. G., et al. (2016). Burden of sickle cell trait and disease in sub-Saharan Africa: A public health challenge. The Lancet Haematology, 3(8), e347–e348. https://doi.org/10.1016/S2352-3026(16)30090-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Lenard Ngoobi, Anthony Ssekitoleko, Franscisco Ssemuwemba, Hasifah Nansereko, Jane Frank Nalubega, Immaculate Prosperia Naggulu
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
